Skip to main content
SpringerLink
Log in

Indolent T-/NK-Cell Lymphoproliferative Disorders

  • Chapter
  • First Online:
Practical Lymph Node and Bone Marrow Pathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 1461 Accesses

Abstract

While the majority of NK/T-cell neoplasms are unfavorable in clinical outcome, a few pathologic variants demonstrate relatively indolent behavior. These include primarily four types of tissue-based T-cell or NK-cell lymphoproliferative disorders and two leukemic forms of T-cell or NK-cell lymphoproliferative disorder. The diagnostic criteria and other clinicopathologic features of these entities are discussed as question and answer format.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shah MV, Hook CC, Call TG, Go RS. A population-based study of large granular lymphocyte leukemia. Blood Cancer J. 2016;6:e455.

    Article  CAS  Google Scholar 

  2. Chan WC, Foucar K, Morice WG, Matutes E. T-cell large granulocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of tumors of haematopoietic and lymphoid tissue. Revised 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2017.

    Google Scholar 

  3. Oshimi K. Clinical features, pathogenesis, and treatment of large granular lymphocyte leukemia. Intern Med. 2017;56:1759–69.

    Article  CAS  Google Scholar 

  4. Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell granular lymphocyte leukemia. Blood. 2012;120:3048–57.

    Google Scholar 

  5. Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, et al. T-cell large granular lymphocytic leukemia and coexisting B-cell lymphomas: A study from the Bone Marrow Pathology Group. Am J Clin Pathol. 2018;149:164–71.

    Google Scholar 

  6. Kataria A, Cohen E, Saad E, Atallah E, Bresnahan B. Large granular lymphocytic leukemia presenting later after solid organ transplantation: a case series of four patients and review of the literature. Transplant Proc. 2014;46:3278–81.

    Google Scholar 

  7. Lundell R, Hartung L, Hill S, Perkins SL, Bahler DW. T-cell large granular lymphocytes leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol. 2005;124:937–46.

    Article  CAS  Google Scholar 

  8. Lima M, Almeida J, Dos Anjos Teixeira M, Alguero Md Mdel C, Santos AH, Balanzategui A, et al. TCRalphabeta(+)/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol. 2003;163:763–71.

    Google Scholar 

  9. Chen YH, Chadburn A, Evens AM, Winter JN, Gordon LI, Chenn A, et al. Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8- γδ T-cell large granular lymphocytic leukemia. Am J Clin Pathol. 2011;136:289–99.

    Google Scholar 

  10. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, et al. Distinguishing between hepatosplenic T-cell lymphoma and gd T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis. Am J Surg Pathol. 2017;41:82–93.

    Google Scholar 

  11. Singleton TP, Yin B, Teferra A, Mao JZ. Spectrum of clonal large granular lymphocytes (LGLs) of ab T cells: T-cell clones of undetermined significance, T-cell LGL leukemias, and T-cell immunoclones. Am J Clin Pathol. 2015;144:137–44.

    Google Scholar 

  12. Zhang X, Sokol L, Bennett JM, Moscinski LC, List A, Zhang L. T-cell large granular lymphocytes proliferation in myelodysplastic syndromes: Clinicopathologic features and prognostic significance. Leuk Res. 2016;43:18–23.

    Article  Google Scholar 

  13. Schrenk KG, Krokowski M, Feller AC, Bernhard V, Mügge LO, Oelzner P, et al. Clonal T-LGL population mimicking leukemia in Felty’s syndrome-part of a continuous spectrum of T-LGL proliferation? Ann Hematol. 2013;92:985–7.

    Google Scholar 

  14. Prochorec-Sobieszek M, Rymkiewicz G, Makuch-Lasica H, Majewski M, Michalak K, Rupiński R, et al. Characteristics of T-cell large granular lymphocytes proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Res Ther. 2008;10:R55.

    Google Scholar 

  15. Munoz-Ballester J, Chen-Liang TH, Hurtado AM, Heras I, de Arriba F, García-Malo MD, et al. Persistent cytotoxic T lymphocyte expansion after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutation. Br J Haematol. 2016;172:937–46.

    Google Scholar 

  16. Poch Martell M, Hamad N, Shin E, Moon JH, Sohn SK, Uhm J, et al. Distinctive clinical characteristics and favorable outcomes in patients with large granulocytosis after all-HCT: 12-year follow-up data. Eur J Haematol. 2017;99:160–8.

    Google Scholar 

  17. Nicolae A, Xi L, Pittaluga S, Abdullaev Z, Pack SD, Chen J, et al. Frequent STAT5 mutations in gd hepatosplenic T-cell lymphomas. Leukemia. 2014;28:2244–8.

    Google Scholar 

  18. Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012;366:1905–13.

    Google Scholar 

  19. Bareau B, Rey J, Hamidou M, Donadieu J, Morcet J, Reman O, et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica. 2010;95:1534–41.

    Google Scholar 

  20. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol. 1999;106:96–966.

    Article  Google Scholar 

  21. Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queirós ML, Santos AH, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56−/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol. 2004;165:1117–27.

    Google Scholar 

  22. Pascal V, Schleinitz N, Brunet C, Ravet S, Bonnet E, Lafarge X, et al. Comparative analysis of NK subset distribution in normal and lymphoproliferative disease of granular lymphocytes conditions. Eur J Immunol. 2004;34:2930–40.

    Google Scholar 

  23. Epling-Burnetter PK, Painter JS, Chaurasia P, Bai F, Wei S, Djeu JY, et al. Dysregulated Nk receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood. 2004;103:3431–9.

    Google Scholar 

  24. Morice WG, Kurtin PJ, Leison PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukemia. Br J Haematol. 2003;120:1026–36.

    Article  CAS  Google Scholar 

  25. Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, et al. EBV-negative aggressive NK-cell leukemia/lymphoma: clinical, pathologic and genetic features. Am J Surg Pathol. 2017;41:67–74.

    Google Scholar 

  26. De Mel S, Li JB, Abid MB, Tang T, Tay HM, Ting WC, et al. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NL cell proliferations. Cytometry B Clin Cytom. 2018;94:159–68.

    Google Scholar 

  27. Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013;122:3599–606.

    Google Scholar 

  28. Edison N, BelhancesPeled H, Eitan Y, Guthmann Y, Yeremenko Y, Raffeld M, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn’s colitis. Hum Pathol. 2016;57:45–50.

    Article  CAS  Google Scholar 

  29. Soon G, Wang S. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract in a renal transplant patient: diagnostic pitfalls and clinical challenges. Pathology. 2017;49:547–50.

    Article  Google Scholar 

  30. Margolskee E, Jobanputra V, Lewis SK, Alobeid B, Green PH, Bhagat G. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One. 2013;8:e68343.

    Google Scholar 

  31. Leventaki V, Manning JT, Luthra R, Mehta P, Oki Y, Romaguera JE, et al. Indolent peripheral T-cell lymphoma involving the gastrointestinal tract. Hum Pathol. 2014;45:421–6.

    Google Scholar 

  32. Umetsu SF, Brown I, Langner C, Lauwers GY. Autoimmune enteropathies. Virchows Arch. 2018;472:55–66.

    Article  CAS  Google Scholar 

  33. Sharma A, Oishi N, Boddicker RL, Hu G, Benson HK, Ketterling RP, et al. Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. Blood. 2018;131:2262–6.

    Google Scholar 

  34. Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S. Screening for celiac disease evidence report and systematic review for the US preventive services task force. JAMA. 2017;317:1258–68.

    Google Scholar 

  35. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447–52.

    Google Scholar 

  36. Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116:5631–7.

    Google Scholar 

  37. Garcia-Herrera A, Colomo L, Camós M, Carreras J, Balague O, Martinez A, et al. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol. 2008;26:3364–71.

    Google Scholar 

  38. Grogg KL, Jung S, Erickson LA, McClure RF, Dogan A. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008;21:708–15.

    Google Scholar 

  39. Petrella T, Maubec E, Cornillet-Lefebvre P, Willemze R, Pluot M, Durlach A, et al. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol. 2007;31:1887–92.

    Article  Google Scholar 

  40. Kluk J, Kai A, Koch D, Taibjee SM, O’Connor S, Persic M, et al. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. J Cutan Pathol. 2016;43:125–36.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Wenbin Xiao

  2. Department of Pathology, University of California San Diego Health System, La Jolla, CA, USA

    Huan-You Wang

Authors
  1. Wenbin Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huan-You Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huan-You Wang .

Editor information

Editors and Affiliations

  1. Department of Pathology, Duke University School of Medicine and Duke Health System, Durham, NC, USA

    Endi Wang

  2. Department of Pathology, Duke University School of Medicine and Duke Health System, Durham, NC, USA

    Anand Shreeram Lagoo

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Xiao, W., Wang, HY. (2020). Indolent T-/NK-Cell Lymphoproliferative Disorders. In: Wang, E., Lagoo, A.S. (eds) Practical Lymph Node and Bone Marrow Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-32189-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-32189-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-32188-8

  • Online ISBN: 978-3-030-32189-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation